RapidCell

RapidCell For Faster, More Efficient Cell Therapy Manufacturing

The RapidCell Collection is a suite of vector technologies developed to address key operational inefficiencies in ex vivo cell therapy workflows. RapidCell enables faster, more cost-effective manufacturing without compromising performance.

This product line supports both lentiviral (LVV) and retroviral (RVV) production platforms and is optimized for targeted delivery to clinically relevant cell populations, including both resting and activated human T cells.

Available Formats

Rapid-T RV Enhancer Plasmid (10ug) - Enables efficient delivery to activated human primary T cells without the need for retronectin or other transduction enhancers. Compatible with RD114 and GALV fusogens.

Rapid-T LV Mix (100 ug) - Pre-formulated plasmid mix including packaging and envelope plasmids. Optimized to activate and transduce resting T cells in a single step—ready to use with your 3rd gen transfer vector.

Why Choose RapidCell?

✔️ Simplifies or bypasses traditional selection and manipulation steps
✔️ Speeds up cell engineering timelines
✔️ Reduces overall manufacturing costs

For Research Use Only.